In order to test this hypothesis, we examined the impact of knocking down hepatic ApoA5 expression by targeted antisense oligonucleotide (ASO) treatment on diet-induced hepatic steatosis and liver and muscle insulin resistance in awake mice. Here, APOA5 is linked to Insulin resistance.